03:41 PM EST - Theralase Technologies Inc. : Has completed detailed information on how the TLC-3000B Laser System will be used to activate the Company’s lead light activated Photo Dynamic Compound, TLD-1433 in the treatment of Non-Muscle Invasive Bladder Cancer. Theralase Technologies Inc.
shares V.TLT are trading up $0.005 at $0.33.
